Unmet Medical Needs in Chronic, Non-Communicable Inflammatory Skin Diseases

    June 2022 in “ Frontiers in medicine
    Hideyuki Ujiie, David Rosmarin, Michael P. Schön, Sonja Ständer, Katharina Boch, Martin Metz, Marcus Maurer, Diamant Thaçi, Enno Schmidt, Connor Cole, Kyle T. Amber, Dario Didona, Michael Hertl, Andreas Recke, Hanna Graßhoff, Alexander Hackel, Anja Schumann, Gabriela Riemekasten, Katja Bieber, Grant Sprow, Joshua Dan, Detlef Zillikens, Tanya Sezin, Angela M. Christiano, Kerstin Wolk, Robert Sabat, Khalaf Kridin, Victoria P. Werth, Ralf J. Ludwig
    Image of study
    TLDR There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.
    Chronic, non-communicable inflammatory skin diseases affect an estimated 20-25% of the population and include conditions such as atopic dermatitis, psoriasis, urticaria, lichen planus, and hidradenitis suppurativa, with causes ranging from genetic to environmental factors, and autoimmune responses that may be T cell or B cell driven. Despite improvements in diagnosis and treatment, challenges persist, including missed early diagnosis for rarer diseases, adverse events from systemic immunosuppression, unpredictable treatment responses, and the need for biomarkers to tailor individual patient treatments. The document suggests optimism for future advancements in addressing these challenges.
    Discuss this study in the Community →

    Cited in this study

    11 / 11 results

    Related

    1 / 1 results